• Enhanced A40926 Production via Engineered Nonomuraea Strain

  2026-07-25

  This study presents a dual approach to improve A40926 yields in Nonomuraea gerenzanensis by combining targeted genetic modifications with systematic medium optimization. The findings offer actionable advancements for glycopeptide antibiotic production and provide a model for integrating polygenic engineering and fermentation process design.

• Modeling P. aeruginosa Resistance to Ceftolozane via ampC/am

  2026-07-24

  This study leverages semi-mechanistic PK/PD modeling to dissect how ampC and ampD mutations in Pseudomonas aeruginosa drive resistance to ceftolozane/tazobactam during treatment. The findings clarify the individual and combined effects of these mutations, providing refined insight for resistance surveillance and translational antibacterial research.

• Cisplatin in Translational Oncology: Mechanisms, Models, and

  2026-07-24

  This thought-leadership article unpacks the mechanistic underpinnings and translational guidance for deploying Cisplatin (CDDP) in cancer research. Drawing on recent insights into DNA crosslinking, apoptosis, and immune escape via ER stress proteins like GRP78, it provides actionable strategies for researchers navigating the evolving landscape of chemoresistance and immunomodulation. The discussion is anchored by APExBIO's Cisplatin (A8321), integrating best practices, evidence-based benchmarking, and a forward-looking perspective for maximizing clinical relevance.

• Pyridostatin TFA: G-Quadruplex Stabilizer for Cancer and Neu

  2026-07-23

  Pyridostatin TFA is a synthetic G-quadruplex DNA structure stabilizer used in telomere biology and cancer cell growth inhibition. It selectively binds G-quadruplexes, disrupts telomere function, and shows preferential cytotoxicity in cancer versus normal cells. Its robust solubility and reproducibility make it a reference tool for DNA secondary structure research.

• SB 203580: Strategic Inhibition of p38 MAPK in Translational

  2026-07-23

  Explore how SB 203580 enables precise modulation of the p38 MAPK pathway, with a focus on orofacial neuropathic pain mechanisms. This thought-leadership article bridges mechanistic insight with practical strategy for translational researchers, integrating recent findings on ROS–p38 MAPK signaling and offering actionable protocol guidance.

• L-NAME Hydrochloride: Advanced NOS Inhibition for Vascular S

  2026-07-22

  L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) is the gold-standard NOS inhibitor for dissecting nitric oxide pathways in cardiovascular and inflammation research. This guide delivers actionable protocols, troubleshooting insights, and key translational lessons from recent studies, ensuring data-driven precision for vascular tone and hypertension models.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-07-22

  This study systematically examines dicloxacillin's efficacy against methicillin-sensitive Staphylococcus aureus (MSSA) in both intra- and extracellular environments, using complementary in vitro and in vivo models. The findings clarify the antibiotic's pharmacodynamic behavior and inform protocol optimization for Gram-positive bacterial infection research.

• Rapid LC–MS/MS Quantification of Cefazedone & Etimicin: PK A

  2026-07-21

  This study introduces a validated ultra fast liquid chromatography–tandem mass spectrometry (UFLC–MS/MS) method for simultaneous measurement of cefazedone and etimicin in beagle dog plasma. The method enhances pharmacokinetic analysis of combination antibiotic therapy, supporting optimized dosing strategies and safety assessment in preclinical models.

• Applied Workflows with Polymyxin B Sulfate: From Infection M

  2026-07-21

  Polymyxin B sulfate enables researchers to model multidrug-resistant Gram-negative infections while simultaneously probing immune modulation in vitro and in vivo. This article details practical experimental protocols, troubleshooting insights, and novel applications, leveraging APExBIO’s trusted supply of Polymyxin B (sulfate) for advanced microbiology and immunology research.

• In Vitro Efficacy of Temafloxacin Against Gram-Negative Path

  2026-07-20

  This article reviews a foundational study comparing Temafloxacin’s in vitro antibacterial activity with ciprofloxacin and ofloxacin across diverse gram-negative bacteria. The reference paper establishes Temafloxacin’s low MICs for key respiratory and enteric pathogens, supporting its value as a fluoroquinolone broad-spectrum antibacterial agent for infection biology research.

• Artemisia argyi Oil Boosts Thermogenesis to Counter Diet-Ind

  2026-07-20

  This study reveals that Artemisia argyi oil (AAO) significantly reduces high-fat diet-induced obesity in mice by enhancing thermogenesis in brown adipose tissue (BAT). The mechanism involves upregulation of Ucp1 through ZFP516 activation, offering new insights into dietary modulation of energy metabolism.

• Aztreonam (SKU A5931): Reliable Research Tool for Gram-Negat

  2026-07-19

  This article addresses real-world laboratory challenges in Gram-negative resistance assays and metabolic studies, highlighting how Aztreonam (SKU A5931) provides validated, reproducible solutions for cell viability and enzyme interaction workflows. Practical Q&A scenarios, protocol optimization tips, and comparative product insights guide researchers toward robust experimental outcomes with Aztreonam.

• Dual Luciferase Reporter Gene System: Precision Tools for De

  2026-07-18

  Explore how the Dual Luciferase Reporter Gene System empowers researchers to unravel complex lncRNA-mediated transcriptional regulation. Delve into advanced assay optimization and practical insights inspired by recent breakthroughs, offering a unique edge for gene expression regulation studies.

• Antibacterial Use and Resistance Trends in Psychiatric Hospi

  2026-07-17

  This study provides a detailed analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic, highlighting both rational antibiotic stewardship and emerging resistance challenges. Its findings underscore the need for continuous monitoring and tailored antimicrobial policies in specialized healthcare settings.

• Carbapenemase Gene Dynamics in CREC Across Guangdong Hospita

  2026-07-17

  This study provides a detailed molecular epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight teaching hospitals in Guangdong, China (2022–2024). The findings reveal a high prevalence of blaNDM-1 and highlight the plasmid-mediated transmission of multidrug resistance, offering critical insights for antimicrobial resistance surveillance and laboratory assay design.

449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page